These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 18940686)

  • 21. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
    Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
    Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
    Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
    Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
    Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors.
    Komeno Y; Kanda Y; Hamaki T; Mitani K; Iijima K; Ueyama J; Yoshihara S; Yuji K; Kim SW; Ando T; Kami M; Yamamoto E; Hiruma K; Mori S; Hirai H; Sakamaki H;
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):408-13. PubMed ID: 16545724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
    Bruns I; Steidl U; Kronenwett R; Fenk R; Graef T; Rohr UP; Neumann F; Fischer J; Scheid C; Hübel K; Haas R; Kobbe G
    Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
    Namba N; Matsuo K; Kubonishi S; Kikuchi T; Maeda Y; Niiya M; Shinagawa K; Koide N; Ikeda K; Tanimoto M
    Transfusion; 2009 Nov; 49(11):2384-9. PubMed ID: 19624602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
    Devine SM; Brown RA; Mathews V; Trinkaus K; Khoury H; Adkins D; Vij R; Sempek D; Graubert T; Tomasson M; Goodnough LT; DiPersio JF
    Bone Marrow Transplant; 2005 Sep; 36(6):531-8. PubMed ID: 16025152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
    Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience.
    Arat M; Arslan O; Ayyildiz E; Topcuoglu P; Dalva K; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):189-91. PubMed ID: 15172622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management strategies for poor peripheral blood stem cell mobilization.
    Moog R
    Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases.
    Lee V; Li CK; Shing MM; Chik KW; Li K; Tsang KS; Zhao DC; Lai DH; Wong A; Yuen PM
    Bone Marrow Transplant; 2000 May; 25(9):931-5. PubMed ID: 10800059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
    Fu P; Bagai RK; Meyerson H; Kane D; Fox RM; Creger RJ; Cooper BW; Gerson SL; Laughlin MJ; Koc ON; Lazarus HM
    Bone Marrow Transplant; 2006 Aug; 38(3):189-96. PubMed ID: 16850032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double apheresis of peripheral blood stem cells in a single day in children mobilized by granulocyte colony-stimulating factor for transplantation.
    Okamoto Y; Watanabe T; Watanabe H; Onishi T; Kawano Y
    Pediatr Transplant; 2009 Jun; 13(4):440-3. PubMed ID: 18992065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harvesting peripheral blood progenitor cells from healthy donors with a short course of recombinant human granulocyte-colony-stimulating factor.
    Martino M; Morabito F; Callea I; Pontari A; Irrera G; Pucci G; Dattola A; Messina G; Console G; Iacopino P
    Transfus Med; 2005 Aug; 15(4):323-8. PubMed ID: 16101811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Collection of peripheral hematopoietic stem cells for transplantation from volunteer donors--siblings of the patients].
    Mayer J; Korístek Z; Krahulová M; Pospísil Z; Doubek M; Klabusay M; Brychtová Y; Hoffová V; Cernanská J; Krejcí M; Vorlícek J
    Vnitr Lek; 2001 Sep; 47 Suppl 1():15-28. PubMed ID: 11693058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
    Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
    Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Zeng DF; Wang QY
    Transfus Apher Sci; 2010 Aug; 43(1):23-8. PubMed ID: 20554478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.